Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Liabilities and Shareholders Equity (2018 - 2025)

Historic Liabilities and Shareholders Equity for AdaptHealth (AHCO) over the last 8 years, with Q3 2025 value amounting to $4.4 billion.

  • AdaptHealth's Liabilities and Shareholders Equity fell 193.32% to $4.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $17.7 billion, marking a year-over-year decrease of 185.93%. This contributed to the annual value of $4.5 billion for FY2024, which is 48.14% down from last year.
  • As of Q3 2025, AdaptHealth's Liabilities and Shareholders Equity stood at $4.4 billion, which was down 193.32% from $4.4 billion recorded in Q2 2025.
  • AdaptHealth's 5-year Liabilities and Shareholders Equity high stood at $5.3 billion for Q1 2023, and its period low was $4.4 billion during Q2 2025.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $4.7 billion (2021), whereas its average is $4.8 billion.
  • In the last 5 years, AdaptHealth's Liabilities and Shareholders Equity soared by 57970.54% in 2021 and then plummeted by 1475.83% in 2024.
  • Quarter analysis of 5 years shows AdaptHealth's Liabilities and Shareholders Equity stood at $5.3 billion in 2021, then decreased by 0.59% to $5.2 billion in 2022, then fell by 13.62% to $4.5 billion in 2023, then decreased by 0.48% to $4.5 billion in 2024, then dropped by 2.3% to $4.4 billion in 2025.
  • Its Liabilities and Shareholders Equity was $4.4 billion in Q3 2025, compared to $4.4 billion in Q2 2025 and $4.4 billion in Q1 2025.